Clinical Trial

TO-ChERIsH: Trajectory of Cardiovascular Ageing, Its Determinants and Impact on Health

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Specific Aim 1: To determine longitudinal changes in CV ageing (changes in CV imaging) over time. Hypothesis: There are differences in rates of CV ageing over time. Specific Aim 2: To study determinants of CV ageing To assess how biological pathways affect CV ageing by studying the relationships between biological signatures measured in longitudinal biospecimens are associated with CV ageing. Hypothesis: Antecedent biological markers are associated with progression of CV ageing. Specific Aim 3: To determine the impact of CV ageing progression on the development of clinical CVD and the overall physical, cognitive and functional health of the elderly. Hypothesis: Those with stable CV imaging phenotypes have lower incidence of clinical CVD and also better overall health in ageing, compared to those with rapid deterioration (unhealthy CV ageing).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-08-02; most recent amendment 2025-06-03.
Status change: Recruiting → Active, Not Recruiting 2025-06-03
Trial Details
NCT Number NCT04501562
Lead Sponsor National Heart Centre Singapore
Conditions Cardiac Ageing
Enrollment 500 participants
Start Date 2019-05-13
Primary Completion 2049-12 (estimated)
Study Completion 2049-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-05